Telesis Bio Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Product sales
Royalties and other revenue
Service revenue
Collaboration revenue
Royalties and other revenue
Total revenue
Cost of revenue
Gross profit
Operating expenses:
Research and development
Sales and marketing
General and administrative
Goodwill impairment
Total operating expenses
Loss from operations
Other (expense) income, net:
Interest expense, net
Interest income
Interest expense
Change in fair value of derivative liabilities
Loss on extinguishment of debt
Other expense, net
Total other expense, net
Loss before provision for income taxes
Provision for income taxes
Net loss
Unrealized gain (loss) on available-for-sale short-term investments
Foreign currency translation loss
Total comprehensive loss
Less: redeemable convertible preferred stock dividends
Net loss attributable to common stockholders
Net loss per share attributable to common stock holders
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average common stock outstanding
Basic (in shares)
Diluted (in shares)

Comments